RICKY LEWIS: Open Payments
NPI 1194747584 · ANDALUSIA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,035 in 51 payments from 13 companies in 2025. Trend: 2023 $576 · 2024 $841 · 2025 $1,035
Food & beverage: $1,035
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $209 |
| Novo Nordisk Inc | 10 | $183 |
| PFIZER INC. | 14 | $167 |
| ABBVIE INC. | 6 | $111 |
| Otsuka America Pharmaceutical, Inc. | 3 | $81 |
| Alpha Cognition USA, Inc. | 1 | $76 |
| Lilly USA, LLC | 3 | $52 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Incyte Corporation | 1 | $24 |
Products named: Ozempic, LOKELMA, NURTEC ODT, REXULTI, Zunveyl, VRAYLAR, PAXLOVID, BREZTRI.
Industry payments across AL — which companies pay providers there.
